Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
Clinical trial NCT00992732 · TERMINATED
Trial details
- NCT number
- NCT00992732
- Sponsor
- HemaQuest Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.